Sagiv-Barfi, I., Kohrt, H. E. K., Czerwinski, D. K., Ng, P. P., Chang, B. Y., & Levy, R. (2015). Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. Proc Natl Acad Sci U S A.

Sagiv-Barfi, Idit, Holbrook E. K. Kohrt, Debra K. Czerwinski, Patrick P. Ng, Betty Y. Chang, ja Ronald Levy. "Therapeutic Antitumor Immunity By Checkpoint Blockade Is Enhanced By Ibrutinib, an Inhibitor of Both BTK and ITK." Proc Natl Acad Sci U S A 2015.

Sagiv-Barfi, Idit, et al. "Therapeutic Antitumor Immunity By Checkpoint Blockade Is Enhanced By Ibrutinib, an Inhibitor of Both BTK and ITK." Proc Natl Acad Sci U S A 2015.